🇺🇸 FDA
Company

RELMADA

RELMADA THERAPEUTICS, INC.

RLMD pharma USA

Quick answer

RELMADA is a pharma company (RLMD) headquartered in CORAL GABLES, FL, USA with 6 tracked pipeline programs.

Pipeline (6)

project

NDV-01 (sustained-release gemcitabine-docetaxel)

Bladder (Urothelial, Transitional Cell) Cancer

Phase 3 · small_molecule · active

2 trials project

NDV-01 (sustained-release gemcitabine-docetaxel)

Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)

Phase 3 · small_molecule · terminated

1 trials project

REL-1017

Major Depressive Disorder

Phase 3 · small_molecule · completed

3 trials project

NDV01 intravesical controlled release formulation of gemcitabine and docetaxel

Non Muscle Invasive Bladder Cancer

Phase 2 · small_molecule · active

1 trials project

REL-1017

Depressive Disorder, Major

Phase 2 · small_molecule · completed

1 trials project

REL-1017

Neuropathic Pain

Phase 1 · small_molecule · completed

2 trials

Patents (7)

patent

US 11607407

Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method

Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10624887

Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol

Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9855226

d-methadone for the treatment of psychiatric symptoms

Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9468611

d-Methadone for the treatment of psychiatric symptoms

Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9364430

Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol

Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9125833

Multimodal abuse resistant and extended release opioid formulations

Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8329744

Methods of preventing the serotonin syndrome and compositions for use thereof

Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)